Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol prophylaxis for postoperative delirium after major thoracotomy and laparotomy
IRCT20230607058400N3Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of haloperidol in delirium (2 arms), sponsored by Golestan University of Medical Sciences. Primary endpoint: Incidence of delirium after surgery. Started Dec 2024; status: completed.
02
Drugs
haloperidol
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20230607058400N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230607058400N3.